First- and second-trimester fetal size and asthma outcomes at age 10 years

Steve Turner1, Nanda Prabhu, Peter Danielan

  • 1Academic Child Health, Obstetrics and Gynaecology, University of Aberdeen, Royal Aberdeen Children’s Hospital, Foresterhill, Aberdeen, UK. s.w.turner@abdn.ac.uk

Insights

Smaller fetal size in early pregnancy is linked to a higher risk of childhood asthma and poorer lung function. These associations, including eczema risk, persist into later childhood.

Area of Science:

  • Pediatric respiratory health
  • Fetal development and long-term outcomes
  • Epidemiology of allergic diseases

Background:

  • Early fetal size is correlated with reduced asthma risk and enhanced lung function in young children.
  • Existing research suggests a link between prenatal development and later respiratory health.
  • The persistence of these associations into later childhood requires further investigation.

Purpose of the Study:

  • To determine if associations between early fetal size and asthma symptoms/lung function persist into later childhood.
  • To investigate the relationship between fetal growth patterns and respiratory health outcomes at age 10.
  • To explore the association between fetal size and the development of allergic diseases.

Main Methods:

  • Longitudinal study design tracking fetal measurements from the first and second trimesters.
  • Respiratory questionnaires administered at 10 years of age.
  • Subset of participants underwent spirometry, bronchial challenge testing, and skin-prick testing for detailed phenotyping.

Main Results:

  • A 1 mm increase in first-trimester fetal size correlated with a 6% reduction in asthma risk and a 6 ml increase in FEV1.
  • Reduced first-trimester size was observed in children with asthma at both 5 and 10 years.
  • Persistent low fetal growth was linked to increased asthma risk (OR 2.8) and reduced FEV1 (mean 103 ml), while increasing fetal size was associated with higher eczema risk (OR 2.5).

Conclusions:

  • Reduced fetal size in the first trimester is a significant predictor of increased asthma risk and impaired lung function in childhood.
  • The relative change in fetal size after the first trimester is associated with an increased risk of eczema.
  • These findings highlight the long-term impact of early fetal development on respiratory and allergic health.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: